IBAB Ion Beam Applications SA

IBA - Regulated Information

IBA - Regulated Information

IBA SA - Regulated information



                                                                                                                        November 28th 5:45 pm



Publication made under article 15 of the law of May 2, 2007 relating to the disclosure of major holdings in issuers whose shares are admitted to trading on a regulated market and containing various provisions (Belgian Gazette 12.VI.2007 ) (hereinafter, the “Law”)

 

Under this provision:

"[...] the issuer publishes the total capital, the total number of securities conferring the right to vote and voting rights, as well as, by category, the number of securities conferring the right to vote and voting rights vote, at the latest at the end of each calendar month in which an increase or a decrease in these numbers occurred.

On each publication referred to in the first paragraph, the issuer also mentions, if applicable, the total number of bonds convertible into securities conferring the right to vote and rights materialized or not by securities to the subscription of securities conferring the right to vote not yet issued, the total number of voting rights that would result from the exercise of these conversion or subscription rights and the total number of shares without voting rights. "

The following information are current as of November 09th ,2022

Nature of information  Remark
Amount of capital (EUR)42.502.318,54 
Securities with voting rights =(A)30.282.218This is the basis for calculating the 30% threshold provided in article 5 of the takeover law of April 1, 2007 (Belgian Gazette 26.IV.2007)
Shares with voting rights30.282.218 
Shares with loyalty voting right (section 28 of the articles of association) =(B)8.120.827 
Existing voting rights =[A-B+(B*2)]38.403.045This is the denominator under which must be calculated the quota of voting rights that can give rise to notification in accordance with article 6 of the Law
Bonds convertible into shares (CB)0 
Voting rights that would result of CB conversion0 
Subscription rights (warrants) issued and exercisable20.000 
Voting rights that would result of warrant conversion20.000 
Statutory and legal thresholds (section 35 of the articles of association)1%, 2%, 3%, 4%, 5%, 7.5%, 10%, 15%, etc. par tranche de 5%These are the thresholds under which the crossing, whether upward or downward (including passive crossing), gives rise to notification in accordance with section 6 or 18, §2, of the Law.

Contact person for threshold crossing notifications: .

Shares endowed with the right to vote in loyalty: registered shares recorded in the share register for at least two consecutive years in the name of their holder (section 28 of the articles of association, in accordance with section 7:53 of the Companies and Associations Code).

Following the introduction of the loyalty voting right by decision of the general meeting of March 10, 2020, the calculation method used by IBA to determine the number of shares with the loyalty voting right at any time is the LIFO method (last in, first out), namely: for the same registered shareholder, the shares which the latter most recently acquired are the first shares which will be deducted from his “basket” of registered shares if he transfer shares thereafter.

Statutory ceiling (section 7, paragraph 1, of the articles of association: “No shareholder may, with companies and persons related to him, participate in the voting at general meetings for a number of votes exceeding 35% of the votes attached to all of the shares with voting rights issued by the company”): currently 35% of 38.339.545, i.e. 13.418.840,8 votes.

ISIN Code : Euronext Brussels BE0003766806

 

About IBA

IBA (Ion Beam Applications S.A.) is the world leader in particle accelerator technology. The company is the leading supplier of equipment and services in the field of proton therapy, considered to be the most advanced form of radiation therapy available today. IBA is also a leading player in the fields of industrial sterilization, radiopharmaceuticals and dosimetry. The company, based in Louvain-la-Neuve, Belgium, employs approximately 1,800 people worldwide. IBA is a certified B Corporation (B Corp) meeting the highest standards of verified social and environmental performance.

IBA is listed on the pan-European stock exchange EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB).

More information can be found at:

For further information, please contact:

IBA

Marie Sirault

Paralegal



 

______________________

 

Attachment



EN
28/11/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ion Beam Applications SA

Guy Sips ... (+2)
  • Guy Sips
  • Michiel Declercq
ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

IBA: Large X-ray sterilisation solution sale Proximus: Stijn Bijnens new CEO of Proximus

 PRESS RELEASE

Steri-Tek to boost sterilization capacity of its Texas-based center fi...

Steri-Tek to boost sterilization capacity of its Texas-based center fivefold with IBA’s X-ray irradiation system Louvain-la-Neuve, Belgium, June 18, 2025 –  (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and electron beam and X-ray solutions for industrial advanced irradiation, announced today it has signed a contract with Steri-Tek, a growing irradiation services provider, to install a fully-integrated Be Wide X-ray Solution. IBA’s solution will be installed at Steri-Tek’s service center near Dallas-Fort Worth Metro Area, Texas, which was op...

 PRESS RELEASE

 Steri-Tek va quintupler la capacité de stérilisation de son centre au...

 Steri-Tek va quintupler la capacité de stérilisation de son centre au Texas avec un système d’irradiation par rayons X d’IBA Louvain-la-Neuve, Belgique, le 18 juin 2025 - IBA (Ion Beam Applications S.A.), le leader mondial des technologies d’accélération de particules et des solutions de pointe d'irradiation industrielle par faisceau d'électrons et rayons X, annonce aujourd'hui avoir signé un contrat avec Steri-Tek, un fournisseur de services d'irradiation en pleine croissance, pour installer une solution d’irradiation par rayons X, Be Wide, entièrement intégrée. La solution d'IBA sera ...

 PRESS RELEASE

Procès-verbal de l'Assemblée Générale Ordinaire d'IBA et résultats des...

Procès-verbal de l'Assemblée Générale Ordinaire d'IBA et résultats des votes Information réglementée Assemblée Générale Ordinaire du 11 juin 2025 Belgique, le 16 juin 2025 (17h50) – Ion Beam Applications SA (« IBA ») annonce que l’ensemble des résolutions proposées à ses actionnaires lors de l’Assemblée Générale Ordinaire tenue le 11 juin dernier ont été adoptées à l’unanimité. Parmi celles-ci figurent notamment : L’approbation des comptes annuels pour l’exercice clôturé le 31 décembre 2024 ;L’approbation de la proposition de dividende de 0,24 EUR par action.  Calendrier rel...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch